Immunomodulating active substance

The invention is an immunomodulator-antistressant and allows to protect immune system from depressive influence of chronic emotional stress with this preventing depression in 1.25-2.5 times of immune reaction. It intensifies humoral immune reaction in 1.9-2.3 times and stimulates phagocyte activity of macrophages in 1.3-1.85 times which is especially important for treatment of immunodeficiency states. With the presence of pathological increased immune reaction (autoimmune diseases-rheumatic arthritis, non-specific ulcerative colitis, psoriasis, chronic glomerulonephritis, etc.) it normalises it, suppressing the progress of humoral immune reaction in 4.7-11.8 times.